Brett D. Dufour

2.1k total citations
28 papers, 1.5k citations indexed

About

Brett D. Dufour is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Brett D. Dufour has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 9 papers in Genetics. Recurrent topics in Brett D. Dufour's work include Autism Spectrum Disorder Research (8 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Brett D. Dufour is often cited by papers focused on Autism Spectrum Disorder Research (8 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Brett D. Dufour collaborates with scholars based in United States, Switzerland and Germany. Brett D. Dufour's co-authors include Jodi L. McBride, Joseph P. Garner, Joy A. Mench, Ulziibat Shirendeb, Maria Mańczak, Peizhong Mao, Marcus J. Calkins, P. Hemachandra Reddy, Verónica Martínez‐Cerdeño and Beverly L. Davidson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Brett D. Dufour

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett D. Dufour United States 18 762 507 322 189 180 28 1.5k
Tsuyoshi Koide Japan 25 1.1k 1.4× 439 0.9× 731 2.3× 199 1.1× 380 2.1× 94 2.4k
Charlotte D. Wenger United States 10 473 0.6× 702 1.4× 176 0.5× 134 0.7× 146 0.8× 13 1.2k
Yehezkel Sztainberg United States 15 584 0.8× 219 0.4× 435 1.4× 383 2.0× 238 1.3× 17 1.3k
Erwin B. Defensor United States 17 300 0.4× 238 0.5× 377 1.2× 516 2.7× 382 2.1× 27 1.2k
Dieter Gläser Germany 27 769 1.0× 362 0.7× 394 1.2× 181 1.0× 181 1.0× 90 2.5k
Howard K. Gershenfeld United States 23 634 0.8× 382 0.8× 394 1.2× 147 0.8× 194 1.1× 36 2.1k
Laurence Coutellier United States 20 277 0.4× 471 0.9× 127 0.4× 217 1.1× 343 1.9× 37 1.5k
David J. Anderson United States 11 376 0.5× 436 0.9× 160 0.5× 300 1.6× 212 1.2× 17 1.3k
Neri Kafkafi United States 17 225 0.3× 283 0.6× 118 0.4× 184 1.0× 237 1.3× 24 933
Allison R. Bechard United States 15 305 0.4× 259 0.5× 183 0.6× 143 0.8× 103 0.6× 28 838

Countries citing papers authored by Brett D. Dufour

Since Specialization
Citations

This map shows the geographic impact of Brett D. Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett D. Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett D. Dufour more than expected).

Fields of papers citing papers by Brett D. Dufour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett D. Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett D. Dufour. The network helps show where Brett D. Dufour may publish in the future.

Co-authorship network of co-authors of Brett D. Dufour

This figure shows the co-authorship network connecting the top 25 collaborators of Brett D. Dufour. A scholar is included among the top collaborators of Brett D. Dufour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett D. Dufour. Brett D. Dufour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dufour, Brett D., et al.. (2023). FXTAS Neuropathology Includes Widespread Reactive Astrogliosis and White Matter Specific Astrocyte Degeneration. Annals of Neurology. 95(3). 558–575. 10 indexed citations
2.
Dufour, Brett D., et al.. (2023). Synaptic boutons are smaller in chandelier cell cartridges in autism. PLoS ONE. 18(4). e0281477–e0281477. 2 indexed citations
3.
Salcedo‐Arellano, María Jimena, Brett D. Dufour, Yingratana McLennan, Verónica Martínez‐Cerdeño, & Randi J. Hagerman. (2020). Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiology of Disease. 136. 104740–104740. 84 indexed citations
4.
Dufour, Brett D., Sarwat Amina, & Verónica Martínez‐Cerdeño. (2020). FXTAS presents with upregulation of the cytokines IL12 and TNFα. Parkinsonism & Related Disorders. 82. 117–120. 8 indexed citations
5.
Falcone, Carmen, et al.. (2020). GABAARα2 is Decreased in the Axon Initial Segment of Pyramidal Cells in Specific Areas of the Prefrontal Cortex in Autism. Neuroscience. 437. 76–86. 16 indexed citations
6.
Liguore, William A., Jacqueline S. Domire, Dana Button, et al.. (2019). AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice. Molecular Therapy. 27(11). 2018–2037. 99 indexed citations
7.
Dufour, Brett D. & Jodi L. McBride. (2018). Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease. Neurobiology of Disease. 121. 214–229. 14 indexed citations
8.
Dufour, Brett D. & Jodi L. McBride. (2016). Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease. Experimental Neurology. 283(Pt A). 308–317. 19 indexed citations
9.
Hart, Peter C., Carisa Bergner, Brett D. Dufour, et al.. (2016). Experimental Models of Anxiety for Drug Discovery and Brain Research. Methods in molecular biology. 271–291. 12 indexed citations
10.
Bergner, Carisa, Peter C. Hart, Brett D. Dufour, et al.. (2016). Mouse Models for Studying Depression-Like States and Antidepressant Drugs. Methods in molecular biology. 1438. 255–269. 17 indexed citations
11.
Dufour, Brett D. & Jodi L. McBride. (2015). Intravascular AAV9 Administration for Delivering RNA Silencing Constructs to the CNS and Periphery. Methods in molecular biology. 1364. 261–275. 6 indexed citations
12.
Monteys, Alex Mas, et al.. (2014). Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain. Nucleic Acids Research. 42(21). 13315–13327. 18 indexed citations
13.
Dufour, Brett D., et al.. (2014). Intrajugular Vein Delivery of AAV9-RNAi Prevents Neuropathological Changes and Weight Loss in Huntington's Disease Mice. Molecular Therapy. 22(4). 797–810. 60 indexed citations
14.
Shirendeb, Ulziibat, Marcus J. Calkins, Maria Mańczak, et al.. (2011). Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Human Molecular Genetics. 21(2). 406–420. 306 indexed citations
15.
McBride, Jodi L., Mark R. Pitzer, Ryan L. Boudreau, et al.. (2011). Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease. Molecular Therapy. 19(12). 2152–2162. 185 indexed citations
16.
Garner, Joseph P., et al.. (2011). Reverse-translational biomarker validation of Abnormal Repetitive Behaviors in mice: An illustration of the 4P's modeling approach. Behavioural Brain Research. 219(2). 189–196. 50 indexed citations
17.
Dufour, Brett D., O. Adeola, H.W. Cheng, et al.. (2010). Nutritional up-regulation of serotonin paradoxically induces compulsive behavior. Nutritional Neuroscience. 13(6). 256–264. 28 indexed citations
18.
Kalueff, Allan V., Michael H. Ferkin, Carisa Bergner, et al.. (2010). Neurobiology of Grooming Behavior. Cambridge University Press eBooks. 44 indexed citations
19.
Hart, Peter C., Carisa Bergner, Brett D. Dufour, et al.. (2009). Experimental Models of Anxiety for Drug Discovery and Brain Research. Methods in molecular biology. 1438. 299–321. 52 indexed citations
20.
Gaertner, Hubert, Fabrice Cerini, Brett D. Dufour, et al.. (2008). Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 /CCL4. Protein Engineering Design and Selection. 21(2). 65–72. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsuyoshi Koide Breakdown of academic impact, for papers by Charlotte D. Wenger Breakdown of academic impact, for papers by Yehezkel Sztainberg Breakdown of academic impact, for papers by Erwin B. Defensor Breakdown of academic impact, for papers by Dieter Gläser Breakdown of academic impact, for papers by Howard K. Gershenfeld Breakdown of academic impact, for papers by Laurence Coutellier Breakdown of academic impact, for papers by David J. Anderson Breakdown of academic impact, for papers by Neri Kafkafi Breakdown of academic impact, for papers by Allison R. Bechard
Rankless by CCL
2026